Power Law company profile

Agios Pharmaceuticals

Biotech & Life Sciences · Cambridge, United States · Founded 2008 · IPO 2013 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.57B

Market cap · Apr/2026

Revenue

$54M

Latest reported FY

Investors

5 investors on Agios Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 2 investors entered at this stage

Series A 1 investor entered at this stage

Series B+ 2 investors entered at this stage

Global footprint

AI talent share

0.6% of workforce is AI talent
(4 of 655 staff)

Core AI00%

Other AI40.61%

Non-AI workforce65199.39%

Web traffic by country

16K monthly visits
across markets

🇺🇸 United States60.6%

🇬🇧 United Kingdom9.4%

🇮🇳 India8.1%

🇨🇦 Canada6.3%

🇯🇵 Japan5%

Top 5 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo